RxDoctor Payments Data

Imran Akhtar, DO

Adult Reconstructive Orthopaedic Surgery · Latham, NYNPI 1063892560

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (45.9%), travel and lodging and education — rather than concentrated in one kind of arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 22.6%. Reporting peaked in 2019 at $4,024 and has fallen 58.0% since, to $1,692 in 2025. That places this record below the midpoint for adult reconstructive orthopaedic surgery clinicians in NY, where the typical reported total is $11,547.

$9,374in general payments, 2019–2025

Across 134 payments — averaging $69.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$2K
  • Pylant Medical$2K
  • Zimmer Biomet$1K
  • Smith+Nephew$942
  • Johnson & Johnson$722
  • Si-bone, Inc.$655
  • plus $1K from 17 others

What the payments were for

  • Travel & lodging$2,99432%
  • Food & beverage$4,30646%
  • Education$2,07422%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,374 in reported general payments places this provider in the 40th percentile of 85 adult reconstructive orthopaedic surgery providers in New York.

See all adult reconstructive orthopaedic surgery providers in New York

Medicare billing

Part B allowed, 2024
$238,162
Medicare patients
814
Services billed
4,942

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium82$3,535
Celecoxib20$574
Cephalexin44$527
Tramadol Hcl80$366
Oxycodone Hcl54$351
Meloxicam55$207
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen25$189
Methocarbamol11$81
Ibuprofen16$69

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Latham

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →